CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Scientific Advice Application Form

1. Information About the Applicant

2. Product Description

3. Stage of Development

To be eligible for CADTH Scientific Advice, a drug product must be in early stage development at a point where changes in development plans based on Scientific Advice are still possible.

4. Purpose of Application

5.  CADTH Scientific Advice Process

6. Proposed Scientific Advice Meeting

A Scientific Advice staff member will contact you to discuss potential meeting dates. 

7. Briefing Book Content

See Type of Advice Offered by CADTH Scientific Advice for common topics on which advice may be sought.

8. Declaration for the CADTH Scientific Advice Program

9. Permission to Share Information With Patient Representatives

Patient involvement is part of the CADTH Scientific Advice process for every application; however, confidential information from the applicant will be shared with patient representative(s) only with permission of the applicant, as provided below.

Name and title of person providing authorized consent on behalf of the applicant. Providing your name here indicates that you have authority to bind the applicant.